Order Article Reprints

Luo H, Wang L, Gao H, Zhou D, Qiu Y, Yang L, Li J, Du D, Huang X, Zhao Y, et al. Targeting p-FGFR1^Y654 Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis. Biomedicines. 2025; 13(7):1667. https://doi.org/10.3390/biomedicines13071667

Luo, Hong, Liwei Wang, Hui Gao, Daijun Zhou, Yu Qiu, Lijia Yang, Jing Li, Dan Du, Xiaoli Huang, Yu Zhao, and et al. 2025. "Targeting p-FGFR1^Y654 Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis" Biomedicines 13, no. 7: 1667. https://doi.org/10.3390/biomedicines13071667

Luo, H., Wang, L., Gao, H., Zhou, D., Qiu, Y., Yang, L., Li, J., Du, D., Huang, X., Zhao, Y., Qi, Z., Zhang, Y., Huang, X., Sun, L., Xu, T., & Li, D. (2025). Targeting p-FGFR1^Y654 Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis. Biomedicines, 13(7), 1667. https://doi.org/10.3390/biomedicines13071667